Navigation Links
SI-BONE, Inc. Launches SI Joint Women's Health Initiative at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego, March 14 - 17
Date:3/8/2017

SAN JOSE, Calif., March 8, 2017 /PRNewswire/ -- SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant System® ("iFuse"), a triangular shaped minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the launch of the SI Joint Women's Health Initiative at the American Academy of Orthopaedic Surgeons (AAOS) 2017 annual meeting in San Diego.  The inaugural meeting will take place on Thursday, March 16th, with a reception from 5:00pm to 6:30pm followed by a dinner program from 7:00 to 8:30pm.

The SI Joint Women's Health Initiative is a broad based educational program supported by orthopedic spine surgeons, neuro spine surgeons and associated healthcare providers who are passionate about women's health and focused on raising awareness about SI joint disorders in women.  The kick-off meeting at AAOS is open to all surgeons, physician assistants and nurse practititioners who diagnose and treat patients with lower back pain symptoms and who are interested in learning more about how the SI joint can be a contributing factor for women with chronic lower back pain.

Multiple studies have shown that 15 to 30% of all lower back pain can be attributed to the SI joint and of those suffering with SI joint disorders, roughly two-thirds are women.  Anatomic and physiologic gender differences result in women being more susceptible to SI joint injury particularly during pregnancy and delivery.  Approximately half of all women have pelvic pain during pregnancy and one-fourth experience pain after pregnancy1.  Symptoms often disappear after childbirth however, in postpartum women, 20% have significant pain three years following childbirth2.

The opening meeting of the SI Joint Women's Health Initiative at AAOS will be hosted by Alexis Waguespack, MD, from Spine Care Medical Group in New Orleans and honored as a Becker's Spine Review Top 10 Female Orthopedic Surgeon.  The reception will also feature guest speaker Karen Licitra, former Vice President of Johnson & Johnson Global Medical Solutions Group and Fortune 50 Most Powerful Women in Business and Jesi Payne, mother of three and bi-lateral iFuse Implant System® patient recently featured in Cosmopolitan Magazine.

Space is limited but there are seats still available and registration is required.  To register to attend or learn more about this important women's health event, please email Reena Mishra, Director of Product Marketing, at rmishra@si-bone.com.

About SI-BONE, Inc.
SI-BONE, Inc. (San Jose, California) is a leading innovative medical device company dedicated to the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders.  SI-BONE, Inc. first received 510(k) clearance to market its iFuse Implant System ("iFuse") from the Food and Drug Administration (FDA) in November 2008. The CE mark for European commercialization was obtained in November 2010.

About the iFuse Implant System
The iFuse Implant System provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum.  The triangular implant shape, combined with the press fit insertion, is designed to provide immediate fixation by minimizing rotational motion.  The implants have a porous surface that provide an ideal environment for bone ongrowth and ingrowth*, facilitating long-term fusion of the joint.  The iFuse Implant System is the only commercially available SI joint fusion system in the United States with published prospective clinical evidence that demonstrates safety, effectiveness and economic benefits, including three large multicenter studies, two of which are randomized controlled trials.  Currently, there are 50 peer-reviewed publications supporting positive clinical outcomes, safety, biomechanics, and the economic benefits of iFuse (www.si-bone.com/results).  The iFuse Implant is the only SI joint fusion device with an FDA clearance recognizing demonstrated improvements in pain, patient function and quality of life following treatment.

The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.  This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.  Clinical studies have demonstrated that treatment with the iFuse Implant improved pain, patient function, and quality of life.  There are potential risks associated with the iFuse Implant System.  It may not be appropriate for all patients and all patients may not benefit.  For information about the risks, visit: www.si-bone.com/risks

SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. ©2017 SI-BONE, Inc. All Rights Reserved. 9849.030817

1. Wu WH, et al. Pregnancy-related pelvic girdle pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur Spine J. 2004;13:575–89. Epub 2004 Aug 27. 

2. Norén L, et al. Lumbar back and posterior pelvic pain during pregnancy: a 3-year follow-up. Eur Spine J. 2002;11;267-71.

One or more of the individuals named herein may be a past or present SI-BONE employee, paid consultant, investor, clinical trial investigator, or grant recipient. Research described herein may have been supported in whole or in part by SI-BONE.

*Data on file: TR 300401-A and 300359-A

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/si-bone-inc-launches-si-joint-womens-health-initiative-at-the-american-academy-of-orthopaedic-surgeons-annual-meeting-in-san-diego-march-14---17-300419954.html


'/>"/>
SOURCE SI-BONE, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
2. SI-BONE, Inc. annuncia la pubblicazione dei dati sulla sicurezza della sorveglianza post-commercializzazione per i primi 5.319 pazienti trattati con il sistema di impianto iFuse Implant System
3. SI-BONE, Inc. Announces 25,000 iFuse Implant Milestone
4. SI-BONE, Inc. annuncia il raggiungimento di 25.000 impianti iFuse
5. SI-BONE, Inc. franchit le cap des 10 000 interventions chirurgicales
6. SI-BONE, Inc. annuncia il raggiungimento di 10.000 procedure iFuse
7. SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health
8. SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Offices Issuance of Threaded, Fenestrated Implant Method Patent
9. SI-BONE, Inc. Announces AMAs Publication of New Category I CPT Code for MIS SI Joint Fusion
10. SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH
11. SI-BONE, Inc. annuncia unespansione in Europa con la nomina di Eric Schaber al ruolo di Direttore Generale, in Germania e la creazione di una GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease Control ... of October . PhysicianOne Urgent Care is helping communities across ... NY , by offering no-cost* flu shots through the end of ... by certain health insurance regulations. ... best time to get a flu shot is by the end of ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
Breaking Medicine News(10 mins):